number of downloads : ?
File
language
eng
Attribute_del
Chemical Therapeutics
Author
Monma, Hiroyuki
Harashima, Nanae
Inao, Touko
Okano, Shinji
Description
TRAIL and agonistic death receptor-specific antibodies can induce apoptosis in cancer cells with little cytotoxicity to normal cells. To improve TRAIL-induced antitumor effects, we tested its effectiveness in combination with pifithrin (PFT)-μ, which has the potential to inhibit HSP70 function and autophagy, both of which participate in TRAIL resistance in cancer cells. Among the four human pancreatic cancer cell lines tested, MiaPaca-2, Panc-1, and BxPC-3 cells showed varying sensitivities to TRAIL. In MiaPaca-2 and Panc-1 cells, knockdown of HSP70 or beclin-1, the latter an autophagy-related molecule, by RNA interference augmented TRAIL-induced antitumor effects, decreasing cell viability, and increasing apoptosis. On the basis of these findings, we next determined whether the TRAIL-induced antitumor effects could be augmented by its combination with PFT-μ. The combination of TRAIL plus PFT-μ significantly decreased the viability and colony-forming ability of MiaPaca-2 and Panc-1 cells compared with cells treated with either agent alone. When applied alone, PFT-μ increased Annexin V+ cells in both caspase-dependent and -independent manners. It also promoted TRAIL-induced apoptosis and arrested cancer cell growth. Furthermore, PFT-μ antagonized TRAIL-associated NF-κB activation in cancer cells. In a xenograft mouse model, combination therapy significantly inhibited MiaPaca-2 tumor growth compared with treatment with either agent alone. The results of this study suggest protective roles for HSP70 and autophagy in TRAIL resistance in pancreatic cancer cells and suggest that PFT-μ is a promising agent for use in therapies intended to enhance the antitumor effects of TRAIL.
Journal Title
Molecular cancer therapeutics
Volume
12
Issue
4
Start Page
341
End Page
351
ISSN
15357163
Published Date
2013-04
DOI
DOI Date
2017-03-15
PubMed ID
NCID
AA11481959
Publisher
American Association for Cancer Research
NII Type
Journal Article
Format
PDF
Rights
© 2013 American Association for Cancer Research.
Text Version
著者版
Gyoseki ID
e21506
OAI-PMH Set
Faculty of Medicine
このエントリーをはてなブックマークに追加